New: NCI-funded clinical trial search
Mednet Logo
CommunityDermatology

How do you select your first line therapy in patients with CSU?

Does your approach vary significantly based on severity of presentation?
Community PollStarted

How long of a trial of 4x standard dose anti-histamine do you give for severe CSU before considering it a failure and escalating to systemic biologic therapy?

64 physicians have voted

Join Mednetto vote and see how they answered.

2 Answers
Mednet Member
Mednet Member
Dermatology · Herbert Wertheim College of Medicine at Florida International University
Answered on

My basic first-line strategy does not change with severity; what changes is the speed with which I optimize and escalate therapy.

For example, with a patient in whom I am confident the diagnosis is CSU, I begin with a second-generation H1 antihistamine at the standard approved dose, taken regularly-...

Join for free or sign in to see the full answer

Mednet Member
Mednet Member
Dermatology · University of Saskatchewan
Answered on

First, I would want to confirm the diagnosis and phenotype: Urticaria only, angioedema, or both, recurring for at least six weeks without a consistent inducible trigger. My first-line treatment is one modern second-generation H1 antihistamine with low sedating potential taken regularly at the licens...

Join for free or sign in to see the full answer